N/A
N=58
Validation of the Hospital Asthma Severity Score (HASS)
Asthma
Bottom Line
View on ClinicalTrials.gov: NCT02782065 ↗Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Inter-rater Reliability for the Hospital Asthma Severity Score (HASS) — 29 percentage of agreement between raters
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Not an interventional study (Other)
- Age
- Pediatric, Adult · 2+ yrs
- Sex
- All
- Sponsor
- Boston Children's Hospital
- Primary completion
- Jan 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Inter-rater Reliability for the Hospital Asthma Severity Score (HASS) |
29 | — |
| PRIMARY Inter-rater Reliability for the Pediatric Respiratory Assessment Measure (PRAM) |
28 | — |
| PRIMARY Intra-rater Reliability Between HASS and PRAM |
71; 64 | — |
| PRIMARY Correlation Between the HASS and Forced Expiratory Volume in 1 Second (FEV1) |
-.31 | — |
| PRIMARY Correlation Between the PRAM and FEV1 |
-.30 | — |
Summary
The purpose of this research will be to evaluate the reliability and validity of the HASS tool in a cohort of patients' ages 7 to18 years old against the gold standard of spirometry, and in ages 2 to 6 against spirometry, if possible, and the most similar validated tool, the PRAM.
Eligibility Criteria
Inclusion Criteria
- asthma exacerbation
Exclusion Criteria
- continuous albuterol and/or
- pneumonia, croup, varicella, cystic fibrosis, broncho-pulmonary dysplasia, cardiac or kidney disease AND
- previously approached for participation in the study
Data sourced from ClinicalTrials.gov (NCT02782065). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.